Log In
BCIQ
Print this Print this
 

AM0012

  Manage Alerts
Collapse Summary General Information
Company Armo BioSciences Inc.
DescriptionRecombinant human interleukin-12 (IL-12)
Molecular Target Interleukin-12 (IL-12)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today